Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New MRI dye could cut dose in half for heart scar detection

NCT ID NCT05954559

First seen Apr 23, 2026 · Last updated May 23, 2026 · Updated 2 times

Summary

This study looks at whether a new MRI contrast agent called Elucirem can detect scarring in the heart muscle as well as the standard agent Dotarem, but using a much lower dose. Researchers will compare images from 25 adults who previously had a heart MRI with Dotarem. If successful, this could mean less dye and lower risk for patients needing heart scar assessment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOCARDIAL FIBROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Johns Hopkins Center for Advanced Imaging and Research Science, located in the Science + Technology Park at 1812 Ashland Avenue, Baltimore, MD.

    RECRUITING

    Baltimore, Maryland, 21202, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Johns Hopkins School of Medicine

    NOT_YET_RECRUITING

    Baltimore, Maryland, 21205, United States

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.